Concepta hails successful UK launch of myLotus fertility testing product

Here's the science bit ... myLotus measures a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of fert

Proactive Published 17/12/2018

Share X in f @

Concepta PLC (LON:CPT) has successfully launched in the UK its myLotus testing product for women’s fertility.

The myLotus home-test device allows women to identify their optimal fertile days thereby improving their chances of naturally getting pregnant.

"myLotus could empower you with some properly useful, personal fertility information which may well help you make decisions going forward and COULD help you conceive. We are all so different; this is why #myLotusFertility is brilliant" @thisisalicerose https://t.co/RaWCeUQgYO pic.twitter.com/9ittIrFxs6

— myLotusFertility (@myLotusMonitor) December 11, 2018

The profile and sales of the myLotus device are just commencing but feedback from early users and fertility bloggers has been very positive, Concepta said.

“We will be raising awareness of the value of the myLotus device and its window on fertility over the coming months via an increased online presence, Key Opinion Leaders and marketing of our initial fertility case studies,” said Matthew Walls, the chairman of Concepta.